Congress is considering a bipartisan bill that would correct a seemingly minor -- but in reality quite significant -- oversight in the Inflation Reduction Act. The legislation would protect patients' access to life-saving new drugs for cancer, heart disease, diabetes, mental illnesses, and many other chronic conditions.
The IRA included several important reforms that make healthcare more affordable. The law capped out-of-pocket spending in Medicare Part D, thereby giving millions of seniors much-needed relief at the pharmacy counter. Similarly, the law limited co-pays for insulin to $35 a month -- a move that could save people with diabetes hundreds of dollars annually.
But no law is ever perfect. And one provision in the IRA could end up hurting the very people it's intending to help.
